Pelvic Organ Prolapse Quantification (POP-Q) System: Difference between revisions
mNo edit summary |
mNo edit summary |
||
| Line 6: | Line 6: | ||
</div> | </div> | ||
== Objective == | == Objective == | ||
The International Continence Society (ICS), the American Urogynecologic Society (AUGS) and the Society of Gynecologic Surgeons came to agreement in 1996, for a graded objective measure to be used in the assessment of female pelvic organ prolapse<ref>Persu C, Chapple CR, Cauni V, Gutue S, Geavlete P. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056425/ Pelvic Organ Prolapse Quantification System (POP–Q)–a new era in pelvic prolapse staging]. Journal of medicine and life. 2011 Feb 15;4(1):75.</ref><ref name=":0">Madhu C, Swift S, Moloney‐Geany S, Drake MJ. [https://onlinelibrary.wiley.com/doi/full/10.1002/nau.23740 How to use the Pelvic Organ Prolapse Quantification (POP‐Q) system?]. Neurourology and Urodynamics. 2018 Aug;37(S6):S39-43.</ref>. This system provides characterisation of a woman's prolapse and allows a uniform recording method to be used by clinicians that enables contrast and disclosure of findings<ref name=":0" />. This system was named the 'Pelvic Organ Prolapse Quantification (POP-Q) System' and is generally used in clinical setting <ref>Muir TW, Stepp KJ, Barber MD. [https://www.ajog.org/article/S0002-9378(03)01119-0/fulltext Adoption of the pelvic organ prolapse quantification system in peer-reviewed literature]. American journal of obstetrics and gynecology. 2003 Dec 1;189(6):1632-5.</ref>. POP-Q is the more routinely used 'staging system' seen in published research<ref>Boyd SS, O'Sullivan DM, Tulikangas P. 29: [https://www.ajog.org/action/showPdf?pii=S0002-9378%2816%2946366-0 Implementation of the pelvic organ prolapse quantification system in peer-reviewed journals]. American Journal of Obstetrics & Gynecology. 2017 Mar 1;216(3):S591.</ref>. | The International Continence Society (ICS), the American Urogynecologic Society (AUGS) and the Society of Gynecologic Surgeons came to agreement in 1996, for a graded objective measure to be used in the assessment of female [[Pelvic Organ Prolapse|pelvic organ prolapse]]<ref name=":1">Persu C, Chapple CR, Cauni V, Gutue S, Geavlete P. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056425/ Pelvic Organ Prolapse Quantification System (POP–Q)–a new era in pelvic prolapse staging]. Journal of medicine and life. 2011 Feb 15;4(1):75.</ref><ref name=":0">Madhu C, Swift S, Moloney‐Geany S, Drake MJ. [https://onlinelibrary.wiley.com/doi/full/10.1002/nau.23740 How to use the Pelvic Organ Prolapse Quantification (POP‐Q) system?]. Neurourology and Urodynamics. 2018 Aug;37(S6):S39-43.</ref>. This system provides characterisation of a woman's prolapse and allows a uniform recording method to be used by clinicians that enables contrast and disclosure of findings<ref name=":0" />. This system was named the 'Pelvic Organ Prolapse Quantification (POP-Q) System' and is generally used in clinical setting <ref>Muir TW, Stepp KJ, Barber MD. [https://www.ajog.org/article/S0002-9378(03)01119-0/fulltext Adoption of the pelvic organ prolapse quantification system in peer-reviewed literature]. American journal of obstetrics and gynecology. 2003 Dec 1;189(6):1632-5.</ref>. POP-Q is the more routinely used 'staging system' seen in published research<ref>Boyd SS, O'Sullivan DM, Tulikangas P. 29: [https://www.ajog.org/action/showPdf?pii=S0002-9378%2816%2946366-0 Implementation of the pelvic organ prolapse quantification system in peer-reviewed journals]. American Journal of Obstetrics & Gynecology. 2017 Mar 1;216(3):S591.</ref>. | ||
== Intended Population == | == Intended Population == | ||
A woman may present in primary care with symptoms of a 'bulge' or 'heaviness' in her vagina with or without incontinence<ref name=":1" /><ref name=":2">Guidance NI. [https://www.nice.org.uk/guidance/ng123/evidence/evidence-review-g-assessing-pelvic-organ-prolapse-pdf-6725287412 Urinary incontinence and pelvic organ prolapse in women: management:© NICE (2019)] Urinary incontinence and pelvic organ prolapse in women: Management. BJU Int. 2019;123(5):777-803.</ref>. Other symptoms may include urge incontinence, problems voiding or defecation<ref name=":1" />. On visual inspection a prolapse may be observed but this patient group can also be asymptotic and are identified through other routine procedures, for instance a smear test<ref name=":2" />. | |||
== Method of Use == | == Method of Use == | ||
| Line 21: | Line 22: | ||
== Links == | == Links == | ||
[https://www.augs.org/patient-services/pop-q-tool/ POP Q Tool AUGS] | |||
== References == | == References == | ||
<references /> | <references /> | ||
Revision as of 10:19, 16 September 2020
Original Editor - User Name
Top Contributors - Jacintha McGahan, Mila Andreew and Kim Jackson
Objective[edit | edit source]
The International Continence Society (ICS), the American Urogynecologic Society (AUGS) and the Society of Gynecologic Surgeons came to agreement in 1996, for a graded objective measure to be used in the assessment of female pelvic organ prolapse[1][2]. This system provides characterisation of a woman's prolapse and allows a uniform recording method to be used by clinicians that enables contrast and disclosure of findings[2]. This system was named the 'Pelvic Organ Prolapse Quantification (POP-Q) System' and is generally used in clinical setting [3]. POP-Q is the more routinely used 'staging system' seen in published research[4].
Intended Population[edit | edit source]
A woman may present in primary care with symptoms of a 'bulge' or 'heaviness' in her vagina with or without incontinence[1][5]. Other symptoms may include urge incontinence, problems voiding or defecation[1]. On visual inspection a prolapse may be observed but this patient group can also be asymptotic and are identified through other routine procedures, for instance a smear test[5].
Method of Use[edit | edit source]
Evidence[edit | edit source]
Reliability[edit | edit source]
Validity
Responsiveness[edit | edit source]
Links[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 Persu C, Chapple CR, Cauni V, Gutue S, Geavlete P. Pelvic Organ Prolapse Quantification System (POP–Q)–a new era in pelvic prolapse staging. Journal of medicine and life. 2011 Feb 15;4(1):75.
- ↑ 2.0 2.1 Madhu C, Swift S, Moloney‐Geany S, Drake MJ. How to use the Pelvic Organ Prolapse Quantification (POP‐Q) system?. Neurourology and Urodynamics. 2018 Aug;37(S6):S39-43.
- ↑ Muir TW, Stepp KJ, Barber MD. Adoption of the pelvic organ prolapse quantification system in peer-reviewed literature. American journal of obstetrics and gynecology. 2003 Dec 1;189(6):1632-5.
- ↑ Boyd SS, O'Sullivan DM, Tulikangas P. 29: Implementation of the pelvic organ prolapse quantification system in peer-reviewed journals. American Journal of Obstetrics & Gynecology. 2017 Mar 1;216(3):S591.
- ↑ 5.0 5.1 Guidance NI. Urinary incontinence and pelvic organ prolapse in women: management:© NICE (2019) Urinary incontinence and pelvic organ prolapse in women: Management. BJU Int. 2019;123(5):777-803.
